The story of copyright's flagship drug presents a complex case for investors in the drug sector. While initially a blockbuster success, generating vast sums, the patent lapse and the subsequent arrival of cheaper https://knockoff938024.onesmablog.com/the-little-copyright-and-pharma-a-hazardous-investment-83209289